Overview

• FaceAge analyzes facial photographs to estimate biological age, which correlates with health outcomes and survival rates in cancer patients.
• The tool was trained on nearly 59,000 images of healthy individuals and validated on over 6,200 cancer patients, finding they appear biologically five years older on average.
• Higher FaceAge scores are strongly linked to worse survival outcomes, particularly when biological age exceeds 85 years.
• FaceAge outperformed clinicians in predicting short-term life expectancy for patients undergoing palliative radiotherapy, enhancing clinical decision-making.
• Ongoing research aims to expand FaceAge’s applications to other diseases, evaluate factors like cosmetic interventions, and ensure fairness and ethical use.